ALS PATHWAYS Trademark

Trademark Overview

On Monday, May 15, 2017, a trademark application was filed for ALS PATHWAYS with the United States Patent and Trademark Office. The USPTO has given the ALS PATHWAYS trademark a serial number of 87449924. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, July 25, 2025. This trademark is owned by MT Pharma America, Inc.. The ALS PATHWAYS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information for patient and healthcare professional education in the area of amyotrophic lateral sclerosis (ALS); providing interactive and digital information in the fields of disease state and medicine for patients and healthcare professionals in the area of amyotrophic lateral sclerosis (ALS)
als pathways

General Information

Serial Number87449924
Word MarkALS PATHWAYS
Filing DateMonday, May 15, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, July 25, 2025
Registration Number5710431
Registration DateTuesday, March 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements

Goods and ServicesProviding medical information for patient and healthcare professional education in the area of amyotrophic lateral sclerosis (ALS); providing interactive and digital information in the fields of disease state and medicine for patients and healthcare professionals in the area of amyotrophic lateral sclerosis (ALS)
NOT AVAILABLE"ALS"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 11, 2018
Primary Code044
First Use Anywhere DateThursday, August 24, 2017
First Use In Commerce DateThursday, August 24, 2017

Trademark Owner History

Party NameMitsubishi Tanabe Pharma America, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJersey City, NJ 07310
Party NameMitsubishi Tanabe Pharma America, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressJersey City, NJ 07310
Party NameMT Pharma America, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJersey City, NJ 07310
Party NameMT Pharma America, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJersey City, NJ 07310

Trademark Events

Event DateEvent Description
Tuesday, August 8, 2017NON-FINAL ACTION WRITTEN
Thursday, May 18, 2017NEW APPLICATION ENTERED
Friday, May 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 4, 2017ASSIGNED TO EXAMINER
Tuesday, August 8, 2017NON-FINAL ACTION E-MAILED
Tuesday, August 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 9, 2018ASSIGNED TO EXAMINER
Wednesday, January 10, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 10, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 30, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 30, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, January 30, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 30, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, January 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 2, 2018TEAS STATEMENT OF USE RECEIVED
Friday, November 2, 2018USE AMENDMENT FILED
Monday, November 26, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 26, 2018ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
Tuesday, November 27, 2018RESPONSE TO ITU OFFICE ACTION ENTERED
Tuesday, November 27, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 27, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 30, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 20, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 21, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 26, 2019REGISTERED-PRINCIPAL REGISTER
Monday, March 24, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, July 25, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 25, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, July 25, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

pathways amyotrophic providing sclerosis area lateral information healthcare disease state medicine